Overview

Pazufloxacin Mesilate Ear Drops Clinical Trial Protocol

Status:
Unknown status

Trial end date:
2016-02-01

Target enrollment:

Participant gender:

Summary

To investigate the safety, tolerance, dynamic percolation model of single dose usage pazufloxacin mesilate ear drops for patients with acute suppurative otitis media or chronic suppurative otitis media

Phase:

Phase 1

Details

Lead Sponsor:

Lee's Pharmaceutical Limited

Treatments:

Carbamide Peroxide
Fluoroquinolones
Pazufloxacin